• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见对接结构域中的突变影响丝裂原活化蛋白激酶ERK2的催化作用和稳定性。

Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability.

作者信息

Novak Leonore, Petrosino Maria, Pasquo Alessandra, Chaikuad Apirat, Chiaraluce Roberta, Knapp Stefan, Consalvi Valerio

机构信息

Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza University of Rome, 00185 Rome, Italy.

Chair of Pharmacology, Section of Medicine, University of Fribourg, CH-1700 Fribourg, Switzerland.

出版信息

Cancers (Basel). 2023 May 26;15(11):2938. doi: 10.3390/cancers15112938.

DOI:10.3390/cancers15112938
PMID:37296900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10252016/
Abstract

The extracellular-signal-regulated kinase 2 (ERK2), a mitogen-activated protein kinase (MAPK) located downstream of the Ras-Raf-MEK-ERK signal transduction cascade, is involved in the regulation of a large variety of cellular processes. The ERK2, activated by phosphorylation, is the principal effector of a central signaling cascade that converts extracellular stimuli into cells. Deregulation of the ERK2 signaling pathway is related to many human diseases, including cancer. This study reports a comprehensive biophysical analysis of structural, function, and stability data of pure, recombinant human non-phosphorylated (NP-) and phosphorylated (P-) ERK2 wild-type and missense variants in the common docking site (CD-site) found in cancer tissues. Because the CD-site is involved in interaction with protein substrates and regulators, a biophysical characterization of missense variants adds information about the impact of point mutations on the ERK2 structure-function relationship. Most of the P-ERK2 variants in the CD-site display a reduced catalytic efficiency, and for the P-ERK2 D321E, D321N, D321V and E322K, changes in thermodynamic stability are observed. The thermal stability of NP-ERK2 and P-ERK2 D321E, D321G, and E322K is decreased with respect to the wild-type. In general, a single residue mutation in the CD-site may lead to structural local changes that reflects in alterations in the global ERK2 stability and catalysis.

摘要

细胞外信号调节激酶2(ERK2)是一种丝裂原活化蛋白激酶(MAPK),位于Ras-Raf-MEK-ERK信号转导级联的下游,参与多种细胞过程的调控。ERK2通过磷酸化激活,是将细胞外刺激转化为细胞内信号的核心信号级联的主要效应器。ERK2信号通路的失调与许多人类疾病有关,包括癌症。本研究报告了对癌症组织中常见对接位点(CD位点)的纯合重组人非磷酸化(NP-)和磷酸化(P-)ERK2野生型和错义变体的结构、功能和稳定性数据的全面生物物理分析。由于CD位点参与与蛋白质底物和调节剂的相互作用,错义变体的生物物理特征增加了关于点突变对ERK2结构-功能关系影响的信息。CD位点中的大多数P-ERK2变体显示出催化效率降低,对于P-ERK2 D321E、D321N、D321V和E322K,观察到热力学稳定性的变化。与野生型相比,NP-ERK2和P-ERK2 D321E、D321G和E322K的热稳定性降低。一般来说,CD位点中的单个残基突变可能导致结构局部变化,这反映在ERK2整体稳定性和催化作用的改变上。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/582c2c513d1d/cancers-15-02938-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/90a02149ef85/cancers-15-02938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/f13bbdf54fa7/cancers-15-02938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/5e5c43a3a2fb/cancers-15-02938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/250485c6709e/cancers-15-02938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/ace7d3607565/cancers-15-02938-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/fa1032fc4133/cancers-15-02938-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/06b5e43c6411/cancers-15-02938-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/582c2c513d1d/cancers-15-02938-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/90a02149ef85/cancers-15-02938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/f13bbdf54fa7/cancers-15-02938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/5e5c43a3a2fb/cancers-15-02938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/250485c6709e/cancers-15-02938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/ace7d3607565/cancers-15-02938-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/fa1032fc4133/cancers-15-02938-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/06b5e43c6411/cancers-15-02938-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42a9/10252016/582c2c513d1d/cancers-15-02938-g008.jpg

相似文献

1
Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability.常见对接结构域中的突变影响丝裂原活化蛋白激酶ERK2的催化作用和稳定性。
Cancers (Basel). 2023 May 26;15(11):2938. doi: 10.3390/cancers15112938.
2
The complex impact of cancer-related missense mutations on the stability and on the biophysical and biochemical properties of MAPK1 and MAPK3 somatic variants.癌症相关错义突变对 MAPK1 和 MAPK3 体细胞变异体的稳定性及生物物理和生物化学特性的复杂影响。
Hum Genomics. 2023 Oct 27;17(1):95. doi: 10.1186/s40246-023-00544-x.
3
Common docking domain mutation E322K of the ERK2 gene is infrequent in oral squamous cell carcinomas.ERK2基因常见的对接结构域突变E322K在口腔鳞状细胞癌中并不常见。
Asian Pac J Cancer Prev. 2012;13(12):6155-7. doi: 10.7314/apjcp.2012.13.12.6155.
4
Functional divergence caused by mutations in an energetic hotspot in ERK2.ERK2 中的能量热点突变导致的功能分化。
Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15514-15523. doi: 10.1073/pnas.1905015116. Epub 2019 Jul 11.
5
ERK2 Mutations Affect Interactions, Localization, and Dimerization.ERK2 突变影响相互作用、定位和二聚化。
Biochemistry. 2023 May 2;62(9):1433-1442. doi: 10.1021/acs.biochem.3c00044. Epub 2023 Apr 6.
6
Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.细胞外信号调节激酶2的N端非催化结构域的生化及生物学功能
Mol Cell Biol. 2001 Jan;21(1):249-59. doi: 10.1128/MCB.21.1.249-259.2001.
7
A mutation in the common docking domain of ERK2 in a human cancer cell line, which was associated with its constitutive phosphorylation.一种人类癌细胞系中ERK2共同对接结构域的突变,这与其组成型磷酸化相关。
Int J Oncol. 2005 Dec;27(6):1499-504.
8
A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.细胞外信号调节激酶2(ERK2)被其同源调节因子和底物识别的一种二元机制。
J Biol Chem. 2003 Aug 8;278(32):29901-12. doi: 10.1074/jbc.M303909200. Epub 2003 May 16.
9
Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.丝裂原活化蛋白激酶(MAPK)激酶、MAPK磷酸酶及Elk-1转录因子上的对接位点竞争结合MAPK,且对酶活性至关重要。
Biochem J. 2003 Mar 15;370(Pt 3):1077-85. doi: 10.1042/BJ20021806.
10
Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum.增强的 MAPK1 功能导致 RASopathy 临床谱内的神经发育障碍。
Am J Hum Genet. 2020 Sep 3;107(3):499-513. doi: 10.1016/j.ajhg.2020.06.018. Epub 2020 Jul 27.

引用本文的文献

1
Comprehensive network pharmacology and experimental study to investigate the effect and mechanism of solasonine on breast carcinoma treatment.综合网络药理学与实验研究以探讨茄解碱对乳腺癌治疗的作用及机制。
Cancer Cell Int. 2025 Feb 17;25(1):49. doi: 10.1186/s12935-025-03665-6.
2
Biochemical characterization of the Drosophila insulin receptor kinase and longevity-associated mutants.果蝇胰岛素受体激酶的生化特性及其与寿命相关的突变体。
FASEB J. 2024 Jan;38(1):e23355. doi: 10.1096/fj.202301948R.
3
The complex impact of cancer-related missense mutations on the stability and on the biophysical and biochemical properties of MAPK1 and MAPK3 somatic variants.

本文引用的文献

1
Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials.近年来,蛋白质-蛋白质相互作用调节剂的研发取得了进展:作用机制和临床试验。
Signal Transduct Target Ther. 2020 Sep 23;5(1):213. doi: 10.1038/s41392-020-00315-3.
2
Magnolin exhibits anti-inflammatory effects on chondrocytes via the NF-κB pathway for attenuating anterior cruciate ligament transection-induced osteoarthritis.厚朴酚通过NF-κB信号通路对软骨细胞发挥抗炎作用,以减轻前交叉韧带横断诱导的骨关节炎。
Connect Tissue Res. 2021 Jul;62(4):475-484. doi: 10.1080/03008207.2020.1778679. Epub 2020 Jun 30.
3
Quantifying protein-protein interactions of the acyl carrier protein with solvatochromic probes.
癌症相关错义突变对 MAPK1 和 MAPK3 体细胞变异体的稳定性及生物物理和生物化学特性的复杂影响。
Hum Genomics. 2023 Oct 27;17(1):95. doi: 10.1186/s40246-023-00544-x.
定量酰基辅酶 A 蛋白与溶剂探针的蛋白质-蛋白质相互作用。
Methods Enzymol. 2020;638:321-340. doi: 10.1016/bs.mie.2020.03.016. Epub 2020 Apr 24.
4
Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.赋予 ERK MAP 激酶耐药性、致癌性和固有活性的突变——最新进展。
Cells. 2020 Jan 6;9(1):129. doi: 10.3390/cells9010129.
5
A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors.一项评估 ERK1/2 抑制剂 GDC-0994 在晚期实体瘤患者中的首次人体 I 期研究。
Clin Cancer Res. 2020 Mar 15;26(6):1229-1236. doi: 10.1158/1078-0432.CCR-19-2574. Epub 2019 Dec 17.
6
ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision Medicine.ERK 抑制剂 LY3214996 针对 ERK 通路驱动的癌症:迈向精准医学的治疗方法。
Mol Cancer Ther. 2020 Feb;19(2):325-336. doi: 10.1158/1535-7163.MCT-19-0183. Epub 2019 Nov 19.
7
Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC).发现一种强效和选择性的 ERK1/2(AZD0364)口服抑制剂,在非小细胞肺癌(NSCLC)模型中无论是单药治疗还是联合治疗都具有疗效。
J Med Chem. 2019 Dec 26;62(24):11004-11018. doi: 10.1021/acs.jmedchem.9b01295. Epub 2019 Nov 25.
8
Dual Specificity Phosphatases: From Molecular Mechanisms to Biological Function.双重特异性磷酸酶:从分子机制到生物学功能。
Int J Mol Sci. 2019 Sep 6;20(18):4372. doi: 10.3390/ijms20184372.
9
Functional divergence caused by mutations in an energetic hotspot in ERK2.ERK2 中的能量热点突变导致的功能分化。
Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15514-15523. doi: 10.1073/pnas.1905015116. Epub 2019 Jul 11.
10
A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.一类新型共同 docking 结构域抑制剂,可阻止 ERK2 的激活和底物磷酸化。
ACS Chem Biol. 2019 Jun 21;14(6):1183-1194. doi: 10.1021/acschembio.9b00093. Epub 2019 May 13.